Skip to main content

HB 1292 — New Hampshire

expanding the right to try act to include certain qualifying severe illness and permitting certain regenerative stem cell therapies under the act.

Introduced 2026 session House

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

  • HB 1292 is a bill in the New Hampshire House, 2026 session, introduced December 1, 2025.
  • Sponsored by Erica Layon, with 9 cosponsors.
  • Current status: introduced.
  • Most recent action (October 6, 2026): Interim Study Report: Recommended for Future Legislation 10/05/2026 (Vote 7-6; ).

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Erica Layon

Cosponsors (9): Dan McGuire, Daniel Popovici-Muller, Matt Sabourin dit Choinière, Mary Murphy, Sayra DeVito, Yury Polozov, Cyril Aures, Keith Murphy, Victoria Sullivan

History

  1. Introduced, completed
  2. Passed House, in progress
  3. Passed Senate, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. House Introduced 01/07/2026 and referred to Judiciary HJ 1 P. 14 Milestone
  2. House Public Hearing: 02/11/2026 01:00 pm GP 230
  3. House Executive Session: 02/13/2026 10:00 am GP 158
  4. House Committee Report: Refer for Interim Study 02/13/2026 (Vote 17-1; CC) HC 9 P. 18
  5. House Refer for Interim Study: MA VV 03/05/2026 HJ 6 P. 24
  6. House Executive Session: 09/30/2026 10:00 am GP 230
  7. House Interim Study Report: Recommended for Future Legislation 10/05/2026 (Vote 7-6; ) Latest

Source: Open States. Last checked November 3, 2026. How we keep this accurate ›